RCC
To determine the clinical usefulness of L1-CAM as a therapeutic or prognostic marker molecule in renal cancer patients, we analyzed its expression on a cohort of 282 renal cell carcinoma (RCC) patients.
To determine the clinical usefulness of <span class="gene" id="21097529-2-40-46">L1-CAM</span> as a therapeutic or prognostic marker molecule in renal cancer patients, we analyzed its expression on a cohort of 282 <span class="disease" id="21097529-2-166-186">renal cell carcinoma</span> (<span class="disease" id="21097529-2-188-191">RCC</span>) patients.